New pill targets advanced cancers in early human trial
NCT ID NCT05585320
Summary
This early-stage study is testing a new oral medication called IMM-1-104 in people with advanced solid tumors that have spread. The main goals are to find a safe dose and see if the drug can shrink tumors in cancers like pancreatic, melanoma, and lung cancer. The drug is being tested alone and in combination with other approved treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Duke University Cancer Institute
Durham, North Carolina, 27710, United States
-
Florida Cancer Specialists and Research Institute
Lake Mary, Florida, 32746, United States
-
Hematology Oncology Associates of Central New York
East Syracuse, New York, 13057, United States
-
Levine Cancer Center
Charlotte, North Carolina, 28204, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
NEXT Oncology
San Antonio, Texas, 78229, United States
-
NEXT Oncology
Fairfax, Virginia, 22031, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
SCRI Oncology Partners
Nashville, Tennessee, 27203, United States
-
Sarah Cannon Research Institute
Denver, Colorado, 80218, United States
-
Sarcoma Oncology Center
Santa Monica, California, 90403, United States
-
University of California San Diego
San Diego, California, 92037, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Wisconsin Clinical Science Center
Madison, Wisconsin, 53792, United States
-
Weill Cornell Medicine
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.